U.S. market Closed. Opens in 1 day 5 hours 40 minutes

CNCR | Loncar Cancer Immunotherapy ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
TIL Instil Bio, Inc. 144.35M 3.59%
22.12 -7.87% 576.12% 75.97%
REPL Replimune Group, Inc. 1.08B 3.54%
13.98 -2.31% 122.01% 11.97%
IOVA Iovance Biotherapeutics, Inc. 1.76B 3.47%
5.78 3.03% 116.50% 80.65%
ZYME Zymeworks Inc. 991.15M 3.45%
14.39 2.64% 291.26% 38.86%
ARGX argenx SE 39.16B 3.42%
644.48 -0.46% 31.77% 42.46%
GMAB Genmab A/S 14.19B 3.42%
22.34 -0.45% 74.56% 62.70%
AZN AstraZeneca PLC 230.17B 3.39%
74.22 0.97% 23.61% 38.39%
BMY Bristol-Myers Squibb Company 113.30B 3.39%
55.83 0.07% 28.93% 31.18%
CRSP CRISPR Therapeutics AG 4.11B 3.39%
47.87 -5.07% 61.54% 46.80%
MRK Merck & Co., Inc. 226.40B 3.37%
89.50 2.08% 29.16% 71.04%
NKTR Nektar Therapeutics 171.95M 3.37%
0.9322 -2.58% 288.36% 74.93%
XNCR Xencor, Inc. 1.10B 3.37%
15.74 -0.32% 81.40% 45.37%
REGN Regeneron Pharmaceuticals, Inc. 75.29B 3.36%
700.33 0.62% 36.18% 59.68%
FATE Fate Therapeutics, Inc. 161.73M 3.33%
1.4200 -8.09% 236.51% 35.44%
GILD Gilead Sciences, Inc. 137.03B 3.33%
109.95 -0.07% 25.23% 31.39%
RCUS Arcus Biosciences, Inc. 1.16B 3.32%
11.07 3.07% 286.49% 36.95%
ATRA Atara Biotherapeutics, Inc. 40.95M 3.30%
7.11 -5.45% 769.79% 94.72%
ALLO Allogene Therapeutics, Inc. 454.99M 3.29%
2.1700 -3.77% 677.77% 87.67%
RUBY Rubius Therapeutics, Inc. 3.29%
TRIL Trillium Therapeutics Inc. 3.29%
BLUE bluebird bio, Inc. 39.67M 3.28%
4.08 -42.05% 122.15% 19.19%
IBRX ImmunityBio, Inc. 2.50B 3.28%
3.42 -6.04% 162.94% 29.33%
IMAB I-Mab 74.71M 3.25%
0.9700 0.35% 546.25% N/A
IGMS IGM Biosciences, Inc. 82.06M 3.23%
1.3800 -0.72% 187.84% 100.00%
STTK Shattuck Labs, Inc. 65.40M 3.23%
1.3700 6.20% 586.39% 69.64%
ALXO ALX Oncology Holdings Inc. 59.07M 3.21%
1.1200 0.00% 270.19% 44.23%
LEGN Legend Biotech Corporation 7.28B 3.20%
39.70 2.00% 65.05% 20.22%
BGNE BeiGene, Ltd. 20.21B 3.19%
184.71 0.49% 39.65% 32.18%
MGNX MacroGenics, Inc. 173.23M 3.17%
2.7600 -4.17% 120.94% 20.16%
YMAB Y-mAbs Therapeutics, Inc. 256.19M 3.12%
5.72 -5.30% 299.13% 47.42%
Cash&Other 0.13%
Total holdings: 31 Recognized Stocks: 28 Others: 3
An error has occurred. This application may no longer respond until reloaded. Reload 🗙